Annual SG&A
$69.65 M
-$1.05 M-1.49%
31 December 2023
Summary:
Editas Medicine annual selling, general & administrative expenses is currently $69.65 million, with the most recent change of -$1.05 million (-1.49%) on 31 December 2023. During the last 3 years, it has risen by +$2.08 million (+3.07%). EDIT annual SG&A is now -8.57% below its all-time high of $76.18 million, reached on 31 December 2021.EDIT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$18.09 M
-$118.00 K-0.65%
30 September 2024
Summary:
Editas Medicine quarterly selling, general & administrative expenses is currently $18.09 million, with the most recent change of -$118.00 thousand (-0.65%) on 30 September 2024. Over the past year, it has increased by +$3.10 million (+20.69%). EDIT quarterly SG&A is now -21.38% below its all-time high of $23.01 million, reached on 31 March 2023.EDIT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$5.31 B
-$210.57 M-4.13%
30 September 2024
Summary:
Editas Medicine TTM selling, general & administrative expenses is currently -$5.31 billion, with the most recent change of -$210.57 million (-4.13%) on 30 September 2024. Over the past year, it has dropped by -$5.38 billion (-7354.08%). EDIT TTM SG&A is now -34264.35% below its all-time high of $79.19 million, reached on 30 June 2021.EDIT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.5% | +20.7% | -7354.1% |
| 3 y3 years | +3.1% | +11.8% | -7136.5% |
| 5 y5 years | +26.6% | +15.0% | -8829.1% |
EDIT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.6% | +3.1% | -21.4% | +25.1% | -78.1% | at low |
| 5 y | 5 years | -8.6% | +26.6% | -21.4% | +28.5% | -186.8% | at low |
| alltime | all time | -8.6% | +810.5% | -21.4% | +547.6% | <-9999.0% | at low |
Editas Medicine Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $18.09 M(-0.6%) | $70.09 M(+4.6%) |
| June 2024 | - | $18.21 M(-5.9%) | $66.99 M(+1.5%) |
| Mar 2024 | - | $19.34 M(+33.8%) | $65.98 M(-5.3%) |
| Dec 2023 | $69.65 M(-1.5%) | $14.46 M(-3.5%) | $69.65 M(-4.8%) |
| Sept 2023 | - | $14.99 M(-12.9%) | $73.18 M(-1.7%) |
| June 2023 | - | $17.20 M(-25.2%) | $74.43 M(+0.4%) |
| Mar 2023 | - | $23.01 M(+27.9%) | $74.17 M(+4.9%) |
| Dec 2022 | $70.70 M(-7.2%) | $17.98 M(+10.8%) | $70.70 M(+2.1%) |
| Sept 2022 | - | $16.24 M(-4.1%) | $69.24 M(+0.1%) |
| June 2022 | - | $16.94 M(-13.3%) | $69.19 M(-6.9%) |
| Mar 2022 | - | $19.55 M(+18.3%) | $74.28 M(-2.5%) |
| Dec 2021 | $76.18 M(+12.7%) | $16.53 M(+2.1%) | $76.18 M(+1.0%) |
| Sept 2021 | - | $16.18 M(-26.5%) | $75.44 M(-4.7%) |
| June 2021 | - | $22.03 M(+2.7%) | $79.19 M(+11.2%) |
| Mar 2021 | - | $21.45 M(+35.8%) | $71.25 M(+5.4%) |
| Dec 2020 | $67.58 M(+4.7%) | $15.79 M(-20.8%) | $67.57 M(-1.6%) |
| Sept 2020 | - | $19.94 M(+41.6%) | $68.70 M(+6.5%) |
| June 2020 | - | $14.08 M(-20.8%) | $64.50 M(-0.5%) |
| Mar 2020 | - | $17.77 M(+5.0%) | $64.83 M(+0.4%) |
| Dec 2019 | $64.56 M | $16.92 M(+7.5%) | $64.55 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $15.73 M(+9.2%) | $60.81 M(+4.1%) |
| June 2019 | - | $14.41 M(-17.6%) | $58.41 M(+0.2%) |
| Mar 2019 | - | $17.49 M(+32.7%) | $58.31 M(+6.0%) |
| Dec 2018 | $55.01 M(+8.9%) | $13.18 M(-1.2%) | $55.01 M(-0.9%) |
| Sept 2018 | - | $13.33 M(-6.8%) | $55.52 M(+1.3%) |
| June 2018 | - | $14.31 M(+0.9%) | $54.82 M(+4.6%) |
| Mar 2018 | - | $14.19 M(+3.7%) | $52.40 M(+3.8%) |
| Dec 2017 | $50.50 M(+9.2%) | $13.69 M(+8.3%) | $50.50 M(+1.3%) |
| Sept 2017 | - | $12.63 M(+6.2%) | $49.86 M(+2.8%) |
| June 2017 | - | $11.89 M(-3.2%) | $48.52 M(-0.5%) |
| Mar 2017 | - | $12.29 M(-5.8%) | $48.79 M(+5.5%) |
| Dec 2016 | $46.26 M(+155.7%) | $13.05 M(+15.5%) | $46.26 M(+14.1%) |
| Sept 2016 | - | $11.29 M(-7.1%) | $40.55 M(+21.2%) |
| June 2016 | - | $12.16 M(+24.5%) | $33.46 M(+36.1%) |
| Mar 2016 | - | $9.76 M(+33.0%) | $24.58 M(+35.9%) |
| Dec 2015 | $18.09 M(+136.5%) | $7.34 M(+74.7%) | $18.09 M(+33.6%) |
| Sept 2015 | - | $4.20 M(+28.1%) | $13.55 M(+45.0%) |
| June 2015 | - | $3.28 M(+0.2%) | $9.35 M(+54.1%) |
| Mar 2015 | - | $3.27 M(+17.2%) | $6.07 M(+117.2%) |
| Dec 2014 | $7.65 M | $2.79 M | $2.79 M |
FAQ
- What is Editas Medicine annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Editas Medicine?
- What is Editas Medicine annual SG&A year-on-year change?
- What is Editas Medicine quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Editas Medicine?
- What is Editas Medicine quarterly SG&A year-on-year change?
- What is Editas Medicine TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Editas Medicine?
- What is Editas Medicine TTM SG&A year-on-year change?
What is Editas Medicine annual selling, general & administrative expenses?
The current annual SG&A of EDIT is $69.65 M
What is the all time high annual SG&A for Editas Medicine?
Editas Medicine all-time high annual selling, general & administrative expenses is $76.18 M
What is Editas Medicine annual SG&A year-on-year change?
Over the past year, EDIT annual selling, general & administrative expenses has changed by -$1.05 M (-1.49%)
What is Editas Medicine quarterly selling, general & administrative expenses?
The current quarterly SG&A of EDIT is $18.09 M
What is the all time high quarterly SG&A for Editas Medicine?
Editas Medicine all-time high quarterly selling, general & administrative expenses is $23.01 M
What is Editas Medicine quarterly SG&A year-on-year change?
Over the past year, EDIT quarterly selling, general & administrative expenses has changed by +$3.10 M (+20.69%)
What is Editas Medicine TTM selling, general & administrative expenses?
The current TTM SG&A of EDIT is -$5.31 B
What is the all time high TTM SG&A for Editas Medicine?
Editas Medicine all-time high TTM selling, general & administrative expenses is $79.19 M
What is Editas Medicine TTM SG&A year-on-year change?
Over the past year, EDIT TTM selling, general & administrative expenses has changed by -$5.38 B (-7354.08%)